期刊文献+

661株革兰阴性杆菌耐药性分析

Analysis on the Drug Resistance of 661Gram-negative Bacilli
原文传递
导出
摘要 目的:探讨临床分离革兰阴性杆菌耐药状况,为临床用药提供参考。方法:统计分析我院2006年1月到2007年12月临床分离的661株革兰阴性杆菌的药物敏感试验结果。结果:661株革兰阴性杆菌对亚胺培南耐药率最低(0~1.7%),肠杆菌科细菌对呋喃妥因、头孢他啶、氨曲南、阿米卡星和头孢哌酮耐药率为8.4~54.3%,非发酵菌对哌拉西林/三唑巴坦、头孢他啶、环丙沙星、头孢哌酮和复方新诺明耐药率22.0~66.7%。而青霉素类、一二代头孢菌素、庆大霉素等耐药率大于50%。结论:临床分离的革兰阴性杆菌耐药性较严重,亚胺培南仍是对革兰阴性杆菌最有效药物。 Objective To study the drug resistance pattern of Gram-negative bacilli so as to provide references for rationa1 use of antibiotics in the clinic.Methods The drug resistance of isolated 661 Gram-negative bacilli was analysed retrospectively.Results Gram-negative bacilli shows the lowest resistant rate to imipenem(0~1.7%)while the resistant rate to penicillin,cynnematin and gentamicin were more than 50%.Enterobactericaeae were sensitive to nitrofurantoin,ceftazidime,aztreonam,amikacin,cefoperazone and the re...
出处 《湖南师范大学学报(医学版)》 2008年第2期27-30,共4页 Journal of Hunan Normal University(Medical Sciences)
关键词 革兰阴性杆菌 耐药性 抗菌药物 Gram-negative bacilli drug resistance antimicrobial agents
  • 相关文献

参考文献7

二级参考文献47

  • 1宗志勇,吕晓菊,高燕渝,俞汝佳.产金属β-内酰胺酶的鲍氏不动杆菌在我国内地出现(英文)[J].中国抗生素杂志,2004,29(10):603-606. 被引量:12
  • 2李家泰,李耘,齐慧敏,代表中国细菌耐药监测研究组.2002—2003年中国革兰阴性细菌耐药性监测研究[J].中华检验医学杂志,2005,28(1):19-29. 被引量:296
  • 3李国利,庄玉辉,那学明,曾修超,张敦镕.3种中药对分枝杆菌抗菌作用的研究[J].微生物学通报,1989,16(3):153-157. 被引量:37
  • 4王一兵,李卫光,朱其凤.山东省医院感染监控网下呼吸道感染病原菌分布及耐药性分析[J].中华医院感染学杂志,2005,15(5):490-492. 被引量:42
  • 5王辉,陈民钧,倪语星,陈冬梅,孙自庸,陈燕,赵旺胜,邹雄,俞云松,胡志东,黄心宏,徐英春,谢秀丽,褚云卓,王倩,梅亚宁,田彬,张蓓,孔庆莲,于秀娟,潘玉红.2003—2004年中国十家教学医院革兰阴性杆菌的耐药分析[J].中华检验医学杂志,2005,28(12):1295-1303. 被引量:236
  • 6National Committee for Clinical Laboratory Standard, 2002. Performance Standards for Antimicrobial Susceptibility Testing. NCCLS, Wayne, Pa.
  • 7Rhomberg PR, Jones RN , MYSTIC Study Group. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials:report from the MYSTIC Program (2002) in North America. Diagn Microbiol Infect Dis, 2003,47:365-372.
  • 8Pfaller MA, Jones RN , MYSTIC Study Group. Antimicrobial susceptibility of inducible Amp C β-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents, 2002,19:383-388.
  • 9Sader HS, Biedenbach DJ ,Jones RN. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis, 2003,47:361-364.
  • 10Sader HS, Gales AC, Pfaller MA, et al. Pathogen frequency and resistance patterns in Brazilian hospitals:summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis, 2001,5:200-214.

共引文献521

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部